Nasal mucosal cell membranes

The nasal mucosal cell membrane is a complex biological interface consisting of the lipid bilayers and associated proteins of the epithelial cells lining the nasal cavity, including ciliated, non-ciliated, and goblet cells (Frontiers in Pharmacology: Nasal Epithelial Barrier, 2021). It serves as a primary physical and biochemical barrier that regulates the absorption of inhaled substances and protects the underlying tissue from pathogens and environmental pollutants through mucociliary clearance (Journal of Controlled Release: Nasal mucosal drug delivery, 2015). In a pharmacological context, this structure is not a single therapeutic target but rather a site of drug administration and a barrier to systemic bioavailability. However, the membrane contains numerous specific molecular targets, such as alpha-adrenergic receptors and glucocorticoid receptors, which are utilized by topical decongestants and anti-inflammatory steroids to treat conditions like allergic rhinitis and sinusitis (StatPearls: Nasal Drug Delivery, 2023). The integrity and permeability of these membranes are critical factors in determining the efficacy of intranasal therapies. Pathological states, including chronic inflammation or viral infections, can alter membrane composition and junctional protein expression, leading to impaired barrier function or altered drug transport (Frontiers in Pharmacology: Nasal Epithelial Barrier, 2021).

Other names

Nasal mucosaSchneiderian membraneNasal epitheliumNasal lining

Drugs interact with nasal mucosal cell membranes through passive transcellular diffusion, paracellular transport via tight junctions, or by binding to specific transmembrane proteins such as G protein-coupled receptors (e.g., alpha-adrenergic receptors) and ion channels embedded within the lipid bilayer (StatPearls: Nasal Drug Delivery, 2023).